UPDATE 1-AstraZeneca diabetes drug combination faces delay after FDA rebuff
October 16, 2015 at 03:22 AM EDT
* AstraZeneca predicted $3 bln sales for combination (Adds sales forecasts, more details on drugs and competitors)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.